Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gerna

Showing results (141-150 of 179) with videos related to

Pageof 18
Sort By:
The Journal of Infectious Diseases|December 1, 1992
Human cytomegalovirus infection of the major leukocyte subpopulations and evidence for initial viral replication in polymorphonuclear leukocytes from viremic patientsG Gerna, D Zipeto, E Percivalle, et al.
Journal of Clinical Microbiology|February 1, 1992
Development and clinical significance of a diagnostic assay based on the polymerase chain reaction for detection of human cytomegalovirus DNA in blood samples from immunocompromised patientsD Zipeto, M G Revello, E Silini, et al.
Prenatal Diagnosis|October 1, 1994
Prenatal diagnosis of congenital human cytomegalovirus infectionU Nicolini, A Kustermann, B Tassis, et al.
Antimicrobial Agents and Chemotherapy|April 4, 1998
The Cys607-->Tyr change in the UL97 phosphotransferase confers ganciclovir resistance to two human cytomegalovirus strains recovered from two immunocompromised patientsF Baldanti, M R Underwood, C L Talarico, et al.
Clinical and Diagnostic Laboratory Immunology|November 1, 2001
Comparative analysis of human cytomegalovirus-specific CD4(+) T-cell frequency and lymphoproliferative response in human immunodeficiency virus-positive patientsG Piccinini, G Comolli, E Genini, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1994
Effect of foscarnet induction treatment on quantitation of human cytomegalovirus (HCMV) DNA in peripheral blood polymorphonuclear leukocytes and aqueous humor of AIDS patients with HCMV retinitis. The Italian Foscarnet Study GroupG Gerna, F Baldanti, A Sarasini, et al.
The New Microbiologica|August 12, 1998
Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patientsG Gerna, E Percivalle, F Baldanti, et al.
European Journal of Ophthalmology|April 1, 1996
Intravitreal and systemic foscarnet in the treatment of AIDS-related CMV retinitisM S Tognon, B Turrini, G Masiero, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 8, 2006
Monitoring of human cytomegalovirus-specific CD4 and CD8 T-cell immunity in patients receiving solid organ transplantationG Gerna, D Lilleri, C Fornara, et al.
Journal of Clinical Microbiology|February 3, 2000
High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disordersF Baldanti, P Grossi, M Furione, et al.
Pageof 18

Showing results (141-150 of 179) with videos related to

Sort By:
Pageof 18
The Journal of Infectious Diseases|December 1, 1992
Human cytomegalovirus infection of the major leukocyte subpopulations and evidence for initial viral replication in polymorphonuclear leukocytes from viremic patientsG Gerna, D Zipeto, E Percivalle, et al.
Journal of Clinical Microbiology|February 1, 1992
Development and clinical significance of a diagnostic assay based on the polymerase chain reaction for detection of human cytomegalovirus DNA in blood samples from immunocompromised patientsD Zipeto, M G Revello, E Silini, et al.
Prenatal Diagnosis|October 1, 1994
Prenatal diagnosis of congenital human cytomegalovirus infectionU Nicolini, A Kustermann, B Tassis, et al.
Antimicrobial Agents and Chemotherapy|April 4, 1998
The Cys607-->Tyr change in the UL97 phosphotransferase confers ganciclovir resistance to two human cytomegalovirus strains recovered from two immunocompromised patientsF Baldanti, M R Underwood, C L Talarico, et al.
Clinical and Diagnostic Laboratory Immunology|November 1, 2001
Comparative analysis of human cytomegalovirus-specific CD4(+) T-cell frequency and lymphoproliferative response in human immunodeficiency virus-positive patientsG Piccinini, G Comolli, E Genini, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1994
Effect of foscarnet induction treatment on quantitation of human cytomegalovirus (HCMV) DNA in peripheral blood polymorphonuclear leukocytes and aqueous humor of AIDS patients with HCMV retinitis. The Italian Foscarnet Study GroupG Gerna, F Baldanti, A Sarasini, et al.
The New Microbiologica|August 12, 1998
Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patientsG Gerna, E Percivalle, F Baldanti, et al.
European Journal of Ophthalmology|April 1, 1996
Intravitreal and systemic foscarnet in the treatment of AIDS-related CMV retinitisM S Tognon, B Turrini, G Masiero, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 8, 2006
Monitoring of human cytomegalovirus-specific CD4 and CD8 T-cell immunity in patients receiving solid organ transplantationG Gerna, D Lilleri, C Fornara, et al.
Journal of Clinical Microbiology|February 3, 2000
High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disordersF Baldanti, P Grossi, M Furione, et al.
Pageof 18